\-\ Texto\\:\\ \ \(0\)\
\-\ hypotensive\\ diaphoretic\\ woman\ \(0\)\
\-\ conservative\ \(240\)\
\-\ \\â\\€\\¢\\ type\\ a\\ aortic\\ dissection\ \(0\)\
\-\ \\â\\€\\¢\\ dissection\\ extends\\ into\\ both\\ common\\ carotid\\ arteries\\.\ \(0\)\
\-\ \\â\\€\\¢\\ paraclinoid\\ aneurysm\\ of\\ the\\ right\\ internal\\ carotid\\ artery\ \(0\)\
\-\ marfan\\'s\\ syndrome\\,\\ aortic\\ dissection\\,\\ cerebral\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ aortic\\ dissection\\ \\-\\ other\\ types\ \(0\)\
\-\ \\â\\€\\¢\\ mycotic\\ aneurysm\ \(1\)\
\-\ 53\\ year\\ old\\ woman\\ with\\ marfan\\ syndrome\\.\\ \\ she\\ presents\\ now\\ with\\ sudden\\ onset\\ of\\ chest\\ pain\\.\ \(0\)\
\-\ there\\ is\\ a\\ history\\ of\\ debate\\ as\\ to\\ whether\\ marfan\\'s\\ syndrome\\ is\\ associated\\ with\\ intracranial\\ aneurysms\\.\\ \\ marfan\\'s\\ results\\ from\\ a\\ defect\\ in\\ fibrillin\\,\\ which\\ is\\ a\\ glycoprotein\\ that\\ is\\ a\\ major\\ component\\ of\\ microfibrils\\.\\ \\ the\\ microfibrils\\ are\\ distributed\\ in\\ the\\ elastic\\ tissues\\ \\(including\\ arterial\\ walls\\)\\ throughout\\ the\\ body\\ suggesting\\ their\\ defect\\ could\\ result\\ in\\ aneurysm\\ development\\.\\ \ \(0\)\
\-\ several\\ case\\ reports\\ have\\ described\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ patients\\,\\ and\\ this\\ lead\\ to\\ a\\ variety\\ of\\ studies\\.\\ \\ a\\ neuropathologic\\ study\\ by\\ schievink\\ et\\ al\\ of\\ 7\\ marfan\\'s\\ patients\\ found\\ intracranial\\ aneurysms\\ in\\ 2\\.\\ \\ however\\,\\ this\\ study\\ was\\ limited\\ by\\ small\\ population\\ size\\.\\ \\ another\\ study\\ by\\ van\\ den\\ berg\\ et\\ al\\ of\\ 135\\ patients\\ in\\ a\\ marfan\\'s\\ clinic\\ did\\ not\\ find\\ an\\ increase\\ in\\ symptomatic\\ intracranial\\ aneurysms\\ based\\ on\\ absence\\ of\\ subarachnoid\\ hemorrhage\\;\\ however\\,\\ no\\ neuroimaging\\ was\\ performed\\.\\ in\\ 1999\\,\\ a\\ study\\ by\\ conway\\ et\\ al\\,\\ reviewed\\ autopsy\\ results\\ in\\ 25\\ confirmed\\ marfan\\'s\\ patients\\.\\ \\ only\\ one\\ of\\ these\\ patients\\ had\\ an\\ intracranial\\ aneurysm\\,\\ which\\ they\\ report\\ is\\ not\\ statistically\\ different\\ from\\ the\\ general\\ autopsy\\ population\\.\\ their\\ conclusion\\ was\\ that\\ there\\ is\\ no\\ increased\\ prevalence\\ of\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ patients\\,\\ and\\ these\\ patients\\ do\\ not\\ require\\ routine\\ screening\\ of\\ the\\ intracranial\\ vasculature\\.\ \(0\)\
\-\ in\\ addition\\,\\ \\ murdoch\\ et\\ al\\ evaluated\\ of\\ the\\ cause\\ of\\ death\\ of\\ 56\\ marfan\\'s\\ patients\\,\\ none\\ of\\ which\\ was\\ from\\ intracranial\\ aneurysm\\.\\ \\ \\ \\ these\\ patients\\ typically\\ have\\ a\\ shorter\\ life\\ expectancy\\ \\(mean\\ 39\\ years\\,\\ median\\ 38\\ years\\ in\\ one\\ autopsy\\ series\\)\\.\\ \\ aortic\\ dissection\\,\\ aortic\\ rupture\\ or\\ cardiac\\ failure\\ due\\ to\\ mitral\\ and\\ aortic\\ valve\\ regurgitation\\ are\\ reported\\ as\\ the\\ main\\ causes\\ of\\ patient\\ death\\.\ \(0\)\
\-\ conway\\ et\\ al\\.\\ marfan\\ syndrome\\ is\\ not\\ associated\\ with\\ intracranial\\ aneurysms\\.\\ stroke\\ 1999\\;\\ 30\\:1632\\-1636\ \(0\)\
\-\ van\\ den\\ berg\\ jsp\\ et\\ al\\.\\ is\\ marfan\\ syndrome\\ associated\\ with\\ symptomatic\\ intracranial\\ aneurysms\\?\\ stroke\\ 1996\\;\\ 27\\:\\ 10\\-12\ \(0\)\
\-\ schieving\\ wi\\ et\\ al\\.\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ syndrome\\:\\ an\\ autopsy\\ study\\.\\ neurosurgery\\ 1997\\;\\ 41\\:\\ 866\\-871\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ marfan\\:\\ 0\\.5323996487509545\ \(0\)\
\-\ intracranial\\:\\ 0\\.30748518320445734\ \(0\)\
\-\ aneurysms\\:\\ 0\\.2973002758371306\ \(0\)\
\-\ al\\:\\ 0\\.1932229438163436\ \(0\)\
\-\ et\\:\\ 0\\.19049866774890875\ \(0\)\
\-\ patients\\:\\ 0\\.17588988140495024\ \(0\)\
\-\ autopsy\\:\\ 0\\.17009612503023624\ \(0\)\
\-\ aortic\\:\\ 0\\.16108977908665623\ \(0\)\
\-\ aneurysm\\:\\ 0\\.15871101543856764\ \(0\)\
\-\ dissection\\:\\ 0\\.15776285736451803\ \(0\)\
\-\ syndrome\\:\\ 0\\.1256614918163106\ \(0\)\
\-\ study\\:\\ 0\\.11584639274623312\ \(0\)\
\-\ in\\:\\ 0\\.11234937765969039\ \(0\)\
\-\ microfibrils\\:\\ 0\\.1111146136719073\ \(0\)\
\-\ of\\:\\ 0\\.1087763752003838\ \(0\)\
\-\ den\\:\\ 0\\.10617594534329469\ \(0\)\
\-\ berg\\:\\ 0\\.10617594534329469\ \(0\)\
\-\ conway\\:\\ 0\\.10267190439990422\ \(0\)\
\-\ van\\:\\ 0\\.08435185847067594\ \(0\)\
\-\ is\\:\\ 0\\.07611094313291188\ \(0\)\
\-\ 1999\\:\\ 0\\.06989187792717876\ \(0\)\
\-\ death\\:\\ 0\\.06816264397111199\ \(0\)\
\-\ population\\:\\ 0\\.06573471842749253\ \(0\)\
\-\ stroke\\:\\ 0\\.06461390479481297\ \(0\)\
\-\ by\\:\\ 0\\.059010989316364594\ \(0\)\
\-\ these\\:\\ 0\\.0588535301373769\ \(0\)\
\-\ carotid\\:\\ 0\\.05852650836003172\ \(0\)\
\-\ their\\:\\ 0\\.0576645230447683\ \(0\)\
\-\ paraclinoid\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ fibrillin\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ neuropathologic\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ schievink\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ murdoch\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ schieving\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ wi\\:\\ 0\\.05555730683595365\ \(0\)\
\-\ the\\:\\ 0\\.055455593369277925\ \(0\)\
\-\ associated\\:\\ 0\\.054932233896121264\ \(0\)\
\-\ not\\:\\ 0\\.054858580318118\ \(0\)\
\-\ results\\:\\ 0\\.05414158333141356\ \(0\)\
\-\ symptomatic\\:\\ 0\\.053426509794741464\ \(0\)\
\-\ glycoprotein\\:\\ 0\\.05133595219995211\ \(0\)\
\-\ jsp\\:\\ 0\\.05133595219995211\ \(0\)\
\-\ defect\\:\\ 0\\.050967728617652364\ \(0\)\
\-\ diaphoretic\\:\\ 0\\.04886661803564581\ \(0\)\
\-\ statistically\\:\\ 0\\.04886661803564581\ \(0\)\
\-\ was\\:\\ 0\\.04842935759848799\ \(0\)\
\-\ expectancy\\:\\ 0\\.04792782075682559\ \(0\)\
\-\ which\\:\\ 0\\.04739028371967619\ \(0\)\
\-\ debate\\:\\ 0\\.04575562490813868\ \(0\)\
\-\ elastic\\:\\ 0\\.04575562490813868\ \(0\)\
\-\ 135\\:\\ 0\\.04464526339964428\ \(0\)\
\-\ hypotensive\\:\\ 0\\.04415779311253607\ \(0\)\
\-\ conclusion\\:\\ 0\\.04328629074383237\ \(0\)\
\-\ shorter\\:\\ 0\\.04328629074383237\ \(0\)\
\-\ years\\:\\ 0\\.04259068125560162\ \(0\)\
\-\ distributed\\:\\ 0\\.04252403125755906\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.04217592923533797\ \(0\)\
\-\ from\\:\\ 0\\.041392126065151844\ \(0\)\
\-\ however\\:\\ 0\\.04112439468782911\ \(0\)\
\-\ reviewed\\:\\ 0\\.04017529761632523\ \(0\)\
\-\ an\\:\\ 0\\.03985372529572633\ \(0\)\
\-\ one\\:\\ 0\\.03978090806306395\ \(0\)\
\-\ find\\:\\ 0\\.03970659507103168\ \(0\)\
\-\ mycotic\\:\\ 0\\.03927140087656606\ \(0\)\
\-\ mean\\:\\ 0\\.03830267662155753\ \(0\)\
\-\ prevalence\\:\\ 0\\.037954574599336446\ \(0\)\
\-\ regurgitation\\:\\ 0\\.037954574599336446\ \(0\)\
\-\ mitral\\:\\ 0\\.037787711355923626\ \(0\)\
\-\ 1996\\:\\ 0\\.0376252983336801\ \(0\)\
\-\ variety\\:\\ 0\\.03673246449868727\ \(0\)\
\-\ woman\\:\\ 0\\.036185726359216505\ \(0\)\
\-\ median\\:\\ 0\\.0359539429803237\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.035155964169373805\ \(0\)\
\-\ have\\:\\ 0\\.034709373413237536\ \(0\)\
\-\ 1997\\:\\ 0\\.0343561111847211\ \(0\)\
\-\ vasculature\\:\\ 0\\.034171547745417474\ \(0\)\
\-\ with\\:\\ 0\\.03401292783082689\ \(0\)\
\-\ whether\\:\\ 0\\.03399241343720591\ \(0\)\
\-\ walls\\:\\ 0\\.03258071207625823\ \(0\)\
\-\ 53\\:\\ 0\\.03251110986268574\ \(0\)\
\-\ 56\\:\\ 0\\.03244229413163506\ \(0\)\
\-\ types\\:\\ 0\\.03230695239740648\ \(0\)\
\-\ series\\:\\ 0\\.03185562540569447\ \(0\)\
\-\ valve\\:\\ 0\\.03185562540569447\ \(0\)\
\-\ 41\\:\\ 0\\.03185562540569447\ \(0\)\
\-\ different\\:\\ 0\\.03179379617007466\ \(0\)\
\-\ suggesting\\:\\ 0\\.031320538555459417\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.031263885799028605\ \(0\)\
\-\ lead\\:\\ 0\\.03093460953337227\ \(0\)\
\-\ 38\\:\\ 0\\.030828691604562995\ \(0\)\
\-\ major\\:\\ 0\\.030373615688510255\ \(0\)\
\-\ main\\:\\ 0\\.030276944969896573\ \(0\)\
\-\ that\\:\\ 0\\.03015197702195208\ \(0\)\
\-\ sudden\\:\\ 0\\.030041775698379434\ \(0\)\
\-\ require\\:\\ 0\\.029859967349554463\ \(0\)\
\-\ component\\:\\ 0\\.029771058801204377\ \(0\)\
\-\ evaluated\\:\\ 0\\.02968342955700755\ \(0\)\
\-\ clinic\\:\\ 0\\.02926325418001586\ \(0\)\
\-\ report\\:\\ 0\\.02926325418001586\ \(0\)\
\-\ 39\\:\\ 0\\.02887020636413254\ \(0\)\
\-\ do\\:\\ 0\\.028794551634722304\ \(0\)\
\-\ development\\:\\ 0\\.028719825207638258\ \(0\)\
\-\ extends\\:\\ 0\\.02860942712605542\ \(0\)\
\-\ arterial\\:\\ 0\\.02860942712605542\ \(0\)\
\-\ life\\:\\ 0\\.028500994693742555\ \(0\)\
\-\ another\\:\\ 0\\.02842976432151869\ \(0\)\
\-\ screening\\:\\ 0\\.028220939495633528\ \(0\)\
\-\ described\\:\\ 0\\.02818682104561929\ \(0\)\
\-\ 27\\:\\ 0\\.028152892671521462\ \(0\)\
\-\ addition\\:\\ 0\\.02811915226721946\ \(0\)\
\-\ rupture\\:\\ 0\\.02808559776140495\ \(0\)\
\-\ as\\:\\ 0\\.02791282499818623\ \(0\)\
\-\ increase\\:\\ 0\\.02788806279984029\ \(0\)\
\-\ general\\:\\ 0\\.02788806279984029\ \(0\)\
\-\ limited\\:\\ 0\\.0277282077590411\ \(0\)\
\-\ absence\\:\\ 0\\.027696734162380963\ \(0\)\
\-\ there\\:\\ 0\\.02764611717441428\ \(0\)\
\-\ arteries\\:\\ 0\\.027572441534073136\ \(0\)\
\-\ tissues\\:\\ 0\\.027390633185248158\ \(0\)\
\-\ reports\\:\\ 0\\.027014401194312265\ \(0\)\
\-\ routine\\:\\ 0\\.026903162898139953\ \(0\)\
\-\ conservative\\:\\ 0\\.026821047576817924\ \(0\)\
\-\ failure\\:\\ 0\\.026375549388293736\ \(0\)\
\-\ are\\:\\ 0\\.026364729710778894\ \(0\)\
\-\ causes\\:\\ 0\\.026250491043331953\ \(0\)\
\-\ to\\:\\ 0\\.026055022225359967\ \(0\)\
\-\ result\\:\\ 0\\.026007824383942918\ \(0\)\
\-\ cardiac\\:\\ 0\\.025797395978621834\ \(0\)\
\-\ confirmed\\:\\ 0\\.025616263597098652\ \(0\)\
\-\ throughout\\:\\ 0\\.025549704165202844\ \(0\)\
\-\ studies\\:\\ 0\\.025483864308826182\ \(0\)\
\-\ could\\:\\ 0\\.02526940104316294\ \(0\)\
\-\ based\\:\\ 0\\.02516493660538663\ \(0\)\
\-\ reported\\:\\ 0\\.025021632878392167\ \(0\)\
\-\ did\\:\\ 0\\.024921299020941853\ \(0\)\
\-\ including\\:\\ 0\\.02486188267259577\ \(0\)\
\-\ they\\:\\ 0\\.02482259139179838\ \(0\)\
\-\ 25\\:\\ 0\\.024610906886382622\ \(0\)\
\-\ typically\\:\\ 0\\.024388072490053887\ \(0\)\
\-\ cerebral\\:\\ 0\\.02406840059068267\ \(0\)\
\-\ this\\:\\ 0\\.023874787186791757\ \(0\)\
\-\ now\\:\\ 0\\.023847534946475898\ \(0\)\
\-\ cause\\:\\ 0\\.023666708163838753\ \(0\)\
\-\ size\\:\\ 0\\.02352265112774577\ \(0\)\
\-\ internal\\:\\ 0\\.0234129161336914\ \(0\)\
\-\ type\\:\\ 0\\.02330512345424421\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.023259504309108107\ \(0\)\
\-\ body\\:\\ 0\\.022863616610963394\ \(0\)\
\-\ several\\:\\ 0\\.022793046558310732\ \(0\)\
\-\ no\\:\\ 0\\.022594302207210253\ \(0\)\
\-\ found\\:\\ 0\\.022478559341687805\ \(0\)\
\-\ onset\\:\\ 0\\.02230773550802685\ \(0\)\
\-\ only\\:\\ 0\\.021703770335965197\ \(0\)\
\-\ artery\\:\\ 0\\.0215760413426203\ \(0\)\
\-\ and\\:\\ 0\\.021535974622127568\ \(0\)\
\-\ she\\:\\ 0\\.02068007445736587\ \(0\)\
\-\ performed\\:\\ 0\\.020552476468108958\ \(0\)\
\-\ due\\:\\ 0\\.019969376873389403\ \(0\)\
\-\ common\\:\\ 0\\.019701730757774018\ \(0\)\
\-\ both\\:\\ 0\\.019372899075641558\ \(0\)\
\-\ none\\:\\ 0\\.018985355668447407\ \(0\)\
\-\ increased\\:\\ 0\\.018785903713744907\ \(0\)\
\-\ into\\:\\ 0\\.01846734681012033\ \(0\)\
\-\ chest\\:\\ 0\\.018337692142374948\ \(0\)\
\-\ other\\:\\ 0\\.018041196889677782\ \(0\)\
\-\ small\\:\\ 0\\.017920218086074784\ \(0\)\
\-\ case\\:\\ 0\\.017453150254896316\ \(0\)\
\-\ had\\:\\ 0\\.01730889605932416\ \(0\)\
\-\ presents\\:\\ 0\\.016711878771166776\ \(0\)\
\-\ history\\:\\ 0\\.013272806732789433\ \(0\)\
\-\ pain\\:\\ 0\\.012431358757399757\ \(0\)\
\-\ or\\:\\ 0\\.012085532673879124\ \(0\)\
\-\ right\\:\\ 0\\.011517847719469426\ \(0\)\
\-\ patient\\:\\ 0\\.011299276431631996\ \(0\)\
\-\ year\\:\\ 0\\.010706277281790012\ \(0\)\
\-\ on\\:\\ 0\\.010492167691556063\ \(0\)\
\-\ old\\:\\ 0\\.010281732260371464\ \(0\)\
